Breaking News, Promotions & Moves

Emergent BioSolutions CEO Robert Kramer Sr. to Retire

Haywood Miller will serve as interim CEO.

By: Kristin Brooks

Managing Editor, Contract Pharma

Emergent BioSolutions’ President and CEO, Robert G. Kramer Sr., plans to retire from Emergent. Mr. Kramer will step down from his role and as a member of the board, effective immediately. The Board has appointed Haywood Miller as interim CEO while it conducts a search to identify a new permanent CEO. Mr. Miller, Managing Director at Berkeley Research Group, has served as an advisor to the Company and its executive management team for the last several months. To help ensure a smooth transition, Mr. Kramer will serve as an advisor to the Company until August 1, 2023.
 
“For 24 years, Emergent has created solutions to the world’s most pressing public health threats, delivering medical countermeasures to protect against biological agents like anthrax and smallpox, serious infectious diseases like COVID-19 and Ebola, and the opioid epidemic,” said Mr. Kramer. “Having joined the company shortly after its inception in 1998, I have led and contributed to many teams’ efforts to seize opportunities and overcame obstacles. Together, we have advanced important clinical programs, achieved organic growth and expanded the company through key acquisitions. It has been a privilege to lead this dedicated and passionate team.”
 
Haywood Miller has more than 30 years of professional experience as an executive, business owner, workout professional, private equity and debt investor, and securities and mergers and acquisitions lawyer. As a member of BRG, Mr. Miller has had interim leadership roles with public and private companies and has worked on dozens of engagements with companies facing financial or operational challenges.
 
He was previously a cofounder and executive vice president of Arguss Communications, Inc., a telecommunication infrastructure business and cofounded and was executive vice president and general counsel for Argan, Inc., a manufacturer and marketer of nutraceuticals. Mr. Miller was the executive vice president and general counsel with Jupiter National, Inc., a venture capital investing business development company. He previously worked as a principal with the MCG Capital Corp. Mr. Miller founded and was president and CEO of Renewal Treatment Centers, Inc., a greenfield developer and operator of an eating disorder treatment center. 

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters